Pakistan’s pharmaceutical manufacturing industry has expressed concern over a federal minister’s directives to amend the existing drug pricing mechanism, warning that sudden changes could cripple the industry, disrupt medicine supplies and undermine efforts to ensure the availability of affordable medicines. Industry officials said the existing Drug Pricing Policy, 2018 was endorsed by the Supr